Link Cell Therapies is a biotechnology startup established in 2022 by Stanford founders Robbie Majzner and Crystal Mackall, in collaboration with investors Samsara BioCapital and Sheatree Capital. The company's focal point is the advancement of a cutting-edge logic-gate technology to propel a new era of cell therapies tailored for patients with solid tumors. The distinctive feature of Link's "AND" gates necessitates two cancer-associated targets for a CAR T cell to combat cancer cells, thereby conferring specificity for the annihilation of tumor cells while preserving healthy tissue. With a strong foundation bolstered by additional technologies in the pipeline, Link is poised to accelerate a range of internal therapeutic programs and explore potential collaborations to drive value creation with strategic partners in the biotechnology and life sciences sectors.
Link Cell Therapies
A True CAR T Cell AND-Gate
South San Francisco, United States
22 employees
Biotechnology, Life Sciences
General Information
Get notified when Link Cell Therapies moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Link Cell Therapies
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Link Cell Therapies
Taxonomy: Cell Therapy, Cancer Treatment, Logic-Gate Technology, CAR T Cell Therapy, Oncology, Solid Tumors, Immunotherapy, Precision Medicine, Biomedical Research
No funding data available for Link Cell Therapies yet.
Get notified when Link Cell Therapies raises fundingLink Cell Therapies Alternatives & Competitors
Transforming Cancer Therapy with Our Novel Seed-and-Boost Approach
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
An advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer
FAQ About Link Cell Therapies
Don't just browse. Track.
Signal Tracker monitors Link Cell Therapies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.